Skip to main content
. Author manuscript; available in PMC: 2015 Dec 7.
Published in final edited form as: Nanoscale. 2015 Nov 3;7(45):18848–18862. doi: 10.1039/c5nr05264e

Figure 2.

Figure 2

Factors influencing the pharmacokinetics of nanoparticles (NPs). Size, shape, composition, administration route, and surface modification should be considered for the enhanced targeted therapy mediated by NPs.